Sabin Nsanzimana1, Eric Remera2, Steve Kanters3, Augustin Mulindabigwi2, Amitabh B Suthar4, Jean Paul Uwizihiwe2, Mutagoma Mwumvaneza2, Edward J Mills5, Heiner C Bucher6. 1. Institute of HIV Disease Prevention and Control, Rwanda Biomedical Center, Kigali, Rwanda; Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital, University of Basel, Basel, Switzerland; Swiss Tropical and Public Health Institute, University of Basel, Switzerland. Electronic address: nsabinco@gmail.com. 2. Institute of HIV Disease Prevention and Control, Rwanda Biomedical Center, Kigali, Rwanda. 3. School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada. 4. South African Centre for Epidemiological Modelling and Analysis, University of Stellenbosch, Epidemiology Department, Stellenbosch, South Africa. 5. Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada. 6. Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital, University of Basel, Basel, Switzerland.
Abstract
BACKGROUND: In Rwanda, HIV prevalence among adults aged 15-49 years has been stable at 3% since 2005. The aim of this study was to characterise HIV incidence across Rwanda. METHODS: We did a nationally representative, prospective HIV incidence survey for the period of 2013-14, which used two-stage sampling. We randomly selected 492 villages in the first sampling stage and 14 households per village in the second stage. Participants completed a questionnaire and 14 140 people were tested for HIV. 13 728 participants were HIV negative, and were enrolled in the incidence cohort. Participants were retested and surveyed again after 12 months. Weights were calculated as the inverse of the probability to select the villages and the households. FINDINGS: The study period was from Nov 5, 2013, to Nov 15, 2014. Among 14 222 respondents from 6792 households, 14 140 were tested for HIV and 13 728 were HIV negative. Of 12 593 people who participated in the endpoint data collection activities, 5965 (47·4%) were men and the mean age was 30 years (SD 10·8). 11 237 (89·2%) participants lived in rural areas, 4826 (38·3%) were single, and 7140 (56·7%) were married or cohabitating. During the year, 35 participants had seroconversion, including 13 men and 22 women, resulting in an overall incidence of 0·27 per 100 person-years (95% CI 0·18-0·35). Incidence was 0·21 per 100 person-years (0·10-0·32) in men and 0·32 per 100 person-years (0·19-0·45) in women. Our findings suggested multiple breakouts, with multiple seroconversions occurring in three villages and two households. Incidence was higher in adults aged 36-45 years (0·37 per 100 person-years, 0·12-0·62; adjusted hazard ratio [aHR] 4·49, 95% CI 1·30-14·70) relative to those aged 16-25, higher in western province (0·57 per 100 person-years, 0·31-0·87; aHR 5·90, 1·33-25·28) relative to the northern province, and higher in urban areas (0·65 per 100 person-years, 0·23-1·07; aHR 3·10, 1·28-6·99) than in rural areas. INTERPRETATION: The incidence of HIV in Rwanda was higher than that previously estimated from models, with outbreaks seeming to contribute to the ongoing epidemic. Characterisation of incident infections can help the national HIV programmes to plan for preventive interventions tailored to the most at risk populations. FUNDING: Global Fund to Fight HIV, Tuberculosis and Malaria, WHO Rwanda, UNAIDS Rwanda, and the Government of Rwanda.
BACKGROUND: In Rwanda, HIV prevalence among adults aged 15-49 years has been stable at 3% since 2005. The aim of this study was to characterise HIV incidence across Rwanda. METHODS: We did a nationally representative, prospective HIV incidence survey for the period of 2013-14, which used two-stage sampling. We randomly selected 492 villages in the first sampling stage and 14 households per village in the second stage. Participants completed a questionnaire and 14 140 people were tested for HIV. 13 728 participants were HIV negative, and were enrolled in the incidence cohort. Participants were retested and surveyed again after 12 months. Weights were calculated as the inverse of the probability to select the villages and the households. FINDINGS: The study period was from Nov 5, 2013, to Nov 15, 2014. Among 14 222 respondents from 6792 households, 14 140 were tested for HIV and 13 728 were HIV negative. Of 12 593 people who participated in the endpoint data collection activities, 5965 (47·4%) were men and the mean age was 30 years (SD 10·8). 11 237 (89·2%) participants lived in rural areas, 4826 (38·3%) were single, and 7140 (56·7%) were married or cohabitating. During the year, 35 participants had seroconversion, including 13 men and 22 women, resulting in an overall incidence of 0·27 per 100 person-years (95% CI 0·18-0·35). Incidence was 0·21 per 100 person-years (0·10-0·32) in men and 0·32 per 100 person-years (0·19-0·45) in women. Our findings suggested multiple breakouts, with multiple seroconversions occurring in three villages and two households. Incidence was higher in adults aged 36-45 years (0·37 per 100 person-years, 0·12-0·62; adjusted hazard ratio [aHR] 4·49, 95% CI 1·30-14·70) relative to those aged 16-25, higher in western province (0·57 per 100 person-years, 0·31-0·87; aHR 5·90, 1·33-25·28) relative to the northern province, and higher in urban areas (0·65 per 100 person-years, 0·23-1·07; aHR 3·10, 1·28-6·99) than in rural areas. INTERPRETATION: The incidence of HIV in Rwanda was higher than that previously estimated from models, with outbreaks seeming to contribute to the ongoing epidemic. Characterisation of incident infections can help the national HIV programmes to plan for preventive interventions tailored to the most at risk populations. FUNDING: Global Fund to Fight HIV, Tuberculosis and Malaria, WHO Rwanda, UNAIDS Rwanda, and the Government of Rwanda.
Authors: Andrew D Maher; Tuli Nakanyala; Nicholus Mutenda; Karen M Banda; Dimitri Prybylski; Adam Wolkon; Anna Jonas; Souleymane Sawadogo; Charity Ntema; Melody Regina Chipadze; Grace Sinvula; Annastasia Tizora; Asen Mwandemele; Shaan Chaturvedi; Afiba Manza-A Agovi; Simon Agolory; Ndapewa Hamunime; David W Lowrance; Willi Mcfarland; Sadhna V Patel Journal: JMIR Public Health Surveill Date: 2020-06-24
Authors: Valentina Cambiano; Cheryl C Johnson; Karin Hatzold; Fern Terris-Prestholt; Hendy Maheswaran; Harsha Thirumurthy; Carmen Figueroa; Frances M Cowan; Euphemia L Sibanda; Getrude Ncube; Paul Revill; Rachel C Baggaley; Elizabeth L Corbett; Andrew Phillips Journal: J Int AIDS Soc Date: 2019-03 Impact factor: 5.396
Authors: Brian Rice; Andrew Boulle; Stefan Baral; Matthias Egger; Paul Mee; Elizabeth Fearon; Georges Reniers; Jim Todd; Sandra Schwarcz; Sharon Weir; George Rutherford; James Hargreaves Journal: JMIR Public Health Surveill Date: 2018-04-03
Authors: Alain Placide Nsabimana; Bernard Uzabakiriho; Daniel M Kagabo; Jerome Nduwayo; Qinyouen Fu; Allison Eng; Joshua Hughes; Samuel K Sia Journal: JMIR Public Health Surveill Date: 2018-08-07